1. Anti‐neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia—a case report and review of the literature. (7th December 2022) Authors: Schwarzwald, Anina; Salmen, Anke; León Betancourt, Alejandro Xavier; Diem, Lara; Hammer, Helly; Radojewski, Piotr; Rebsamen, Michael; Kamber, Nicole; Chan, Andrew; Hoepner, Robert; Friedli, Christoph Journal: European journal of neurology Issue: Volume 30:Number 4(2023) Page Start: 1135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study. Issue 2 (March 2020) Authors: Diem, Lara; Daponte, Ariadne; Findling, Oliver; Miclea, Andrei; Briner, Myriam; Salmen, Anke; Gold, Ralf; Kilidireas, Constantinos; Chan, Andrew; Evangelopoulos, Maria Elftheria; Hoepner, Robert Journal: Neurology Issue: Volume 7:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort. (13th October 2020) Authors: Veselaj, Krenar; Kamber, Nicole; Briner, Myriam; Friedli, Christoph; Diem, Lara; Guse, Kirsten; Miclea, Andrei; Wiest, Roland; Wagner, Franca; Grabe, Hilary; Abegg, Mathias; Horn, Michael P.; Bigi, Sandra; Chan, Andrew; Hoepner, Robert; Salmen, Anke Journal: CNS neuroscience & therapeutics Issue: Volume 27:Number 4(2021) Page Start: 426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19. (21st May 2022) Authors: Diem, Lara; Fregolente-Gomes, Livia; Warncke, Jan D.; Hammer, Helly; Friedli, Christoph; Kamber, Nicole; Jung, Simon; Bigi, Sandra; Funke-Chambour, Manuela; Chan, Andrew; Bassetti, Claudio L.; Salmen, Anke; Hoepner, Robert Journal: Journal of central nervous system disease Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients. (January 2023) Authors: Friedli, Christoph; Wagner, Franca; Hammer, Helly Noemi; Kamber, Nicole; Wiest, Roland; Diem, Lara; Chan, Andrew; Salmen, Anke; Hoepner, Robert Journal: Multiple sclerosis Issue: Volume 29:Number 1(2023) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long-term evaluation of NEDA-3 status in relapsing-remitting multiple sclerosis patients after switching from natalizumab to fingolimod. (August 2018) Authors: Diem, Lara; Nedeltchev, Krassen; Kahles, Timo; Achtnichts, Lutz; Findling, Oliver Journal: Therapeutic advances in neurological disorders Issue: Volume 11(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Multidimensional phenotyping of the post‐COVID‐19 syndrome: A Swiss survey study. (16th August 2022) Authors: Diem, Lara; Schwarzwald, Anina; Friedli, Christoph; Hammer, Helly; Gomes‐Fregolente, Livia; Warncke, Jan; Weber, Lea; Kamber, Nicole; Chan, Andrew; Bassetti, Claudio; Salmen, Anke; Hoepner, Robert Journal: CNS neuroscience & therapeutics Issue: Volume 28:Number 12(2022) Page Start: 1953 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Multiple sclerosis as a model to investigate SARS‐CoV‐2 effect on brain atrophy. (7th December 2022) Authors: Rebsamen, Michael; Friedli, Christoph; Radojewski, Piotr; Diem, Lara; Chan, Andrew; Wiest, Roland; Salmen, Anke; Rummel, Christian; Hoepner, Robert Journal: CNS neuroscience & therapeutics Issue: Volume 29:Number 2(2023) Page Start: 538 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies. (May 2021) Authors: Friedli, Christoph; Diem, Lara; Hammer, Helly; Kamber, Nicole; Suter-Riniker, Franziska; Leib, Stephen; Chan, Andrew; Hirzel, Cédric; Hoepner, Robert; Salmen, Anke Journal: Therapeutic advances in neurological disorders Issue: Volume 14(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational study. (December 2020) Authors: Diem, Lara; Bürge, Maxine; Leichtle, Alexander; Hakim, Arsany; Chan, Andrew; Salmen, Anke; Evangelopoulos, Maria-Eleptheria; Hoepner, Robert Journal: Therapeutic advances in neurological disorders Issue: Volume 13(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗